← All trials
NCT03137914
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 8, 2015
- Primary completion
- Jan 2, 2019
- Completion date
- Jan 2, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 10
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Faculdade de Medicina de Petrópolis Faculdade Arthur Sá Earp NetoLead sponsor
- Faculty of Medicine of PetrópolisOverall official - principal investigator
- Faculty of Medicine of PetrópolisStudy director
- Faculty of Medicine of PetrópolisStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.